Search results
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 7 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price hoisted by analysts at Oppenheimer from $163.00 to $179.00 in a research report issued...clients and investors ...
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Benzinga via Yahoo Finance· 6 days agoVaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23%...
Gateway - Quartz
Quartz· 1 day agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
FOX 23 News Albany· 5 days agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton ...
B.Riley lifts Vaxart shares target on BARDA award By Investing.com
Investing.com· 6 days ago(NASDAQ:VXRT) shares to $2.50, up from the previous $2.00, while maintaining a Buy rating on the ...
Worried you missed the Nvidia bandwagon? Here are some alternative stocks.
MarketWatch via Yahoo Finance· 5 days agoIt is interesting to see Tesla on the list. The stock has fallen 27% this year, but it is down only...
Moderna stock is lone omen of bird flu pandemic
Reuters· 3 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Wahed Invest LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoThe firm owned 96,534 shares of the biopharmaceutical company’s stock after buying an additional 7,624 shares during the quarter. Pfizer comprises 0.7% of Wahed Invest LLC ...
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 2 days agoAstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug...
Pfizer (NYSE:PFE) Trading 1.3% Higher
ETF DAILY NEWS· 5 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $27.38 and last traded at $27.32. 8,155,528 shares changed hands during trading, a decline ...
